-
CDK inhibitors: positive and negative regulators of G1-phase progression.
Genes Dev. 1999 Jun 15;13(12):1501-12
PMID: 10385618
-
Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines.
Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10565-9
PMID: 7479841
-
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization.
Genes Dev. 1998 Aug 1;12(15):2424-33
PMID: 9694806
-
Epstein-Barr virus exploits the normal cell pathway to regulate Rb activity during the immortalisation of primary B-cells.
Oncogene. 1996 Oct 3;13(7):1413-21
PMID: 8875979
-
Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice.
J Virol. 2000 Feb;74(3):1101-13
PMID: 10627520
-
p16/INK4a and p15/INK4b gene methylation and absence of p16/INK4a mRNA and protein expression in Burkitt's lymphoma.
Blood. 1998 Mar 1;91(5):1680-7
PMID: 9473234
-
The EBNA-3 gene family proteins disrupt the G2/M checkpoint.
Oncogene. 2004 Feb 19;23(7):1342-53
PMID: 14716295
-
Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes.
Cell Growth Differ. 1990 Dec;1(12):571-80
PMID: 2288874
-
Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression.
Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):1919-24
PMID: 21245331
-
The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization.
J Virol. 1990 Jun;64(6):2530-6
PMID: 2159528
-
The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter.
Virology. 1994 Dec;205(2):596-602
PMID: 7975264
-
BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV.
Nucleic Acids Res. 2012 Aug;40(15):7233-46
PMID: 22584624
-
Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases.
Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4291-6
PMID: 10760295
-
Caspase-dependent proteolysis of integral and peripheral proteins of nuclear membranes and nuclear pore complex proteins during apoptosis.
J Cell Sci. 1999 Jun;112 ( Pt 11):1743-53
PMID: 10318766
-
Chromatin condensation during apoptosis is accompanied by degradation of lamin A+B, without enhanced activation of cdc2 kinase.
J Cell Biol. 1994 Aug;126(4):827-37
PMID: 8051209
-
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature. 1970 Aug 15;227(5259):680-5
PMID: 5432063
-
The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.
EMBO J. 1998 Sep 1;17(17):5001-14
PMID: 9724636
-
The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.
Cell. 1998 Mar 20;92(6):713-23
PMID: 9529248
-
Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase.
Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18562-6
PMID: 16352731
-
Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals.
Immunity. 1998 Sep;9(3):405-11
PMID: 9768760
-
Inhibition of cyclin-dependent kinases by p21.
Mol Biol Cell. 1995 Apr;6(4):387-400
PMID: 7626805
-
The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle.
J Virol. 1989 Jul;63(7):3109-16
PMID: 2542618
-
EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus.
EMBO J. 1994 Jul 15;13(14):3321-8
PMID: 8045261
-
Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers.
J Virol. 1994 Sep;68(9):5602-12
PMID: 7520093
-
Physical and functional interactions between the corepressor CtBP and the Epstein-Barr virus nuclear antigen EBNA3C.
J Virol. 2001 Aug;75(16):7749-55
PMID: 11462050
-
Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells.
Proc Natl Acad Sci U S A. 1982 Dec;79(24):7824-7
PMID: 6961453
-
Epstein-Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell lines.
Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):337-42
PMID: 21173222
-
ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.
Cell. 1998 Mar 20;92(6):725-34
PMID: 9529249
-
EBV infection of human B lymphocytes leads to down-regulation of Bim expression: relationship to resistance to apoptosis.
J Immunol. 2005 Sep 1;175(5):2968-73
PMID: 16116183
-
Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma.
Oncogene. 2008 Jan 17;27(4):421-33
PMID: 17653091
-
Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation.
J Virol. 1993 Apr;67(4):2014-25
PMID: 8445720
-
Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.
Genes Dev. 1999 Oct 15;13(20):2658-69
PMID: 10541552
-
Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE.
Nature. 1994 Sep 22;371(6495):346-7
PMID: 8090205
-
Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim.
Blood. 2010 Dec 9;116(24):5256-67
PMID: 20829369
-
Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.
Nature. 1989 Aug 3;340(6232):393-7
PMID: 2547164
-
Downregulation of p21(WAF1/CIP1) and estrogen receptor alpha in MCF-7 cells by antisense oligonucleotides containing locked nucleic acid (LNA).
Oligonucleotides. 2004;14(2):147-56
PMID: 15294077
-
Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim.
PLoS Pathog. 2009 Jun;5(6):e1000492
PMID: 19557159
-
Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV.
J Virol. 1994 Sep;68(9):6069-73
PMID: 8057484
-
Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex.
Virology. 1987 Sep;160(1):151-61
PMID: 2820125
-
Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site.
Proc Natl Acad Sci U S A. 1986 Jul;83(14):5096-100
PMID: 3460083
-
Epstein-Barr virus can inhibit genotoxin-induced G1 arrest downstream of p53 by preventing the inactivation of CDK2.
Oncogene. 2003 Oct 16;22(46):7181-91
PMID: 14562046
-
Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
Cell Growth Differ. 1996 Dec;7(12):1723-32
PMID: 8959341
-
Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.
J Virol. 1991 May;65(5):2545-54
PMID: 1850028
-
Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14935-40
PMID: 17001014
-
Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency.
J Virol. 1987 Dec;61(12):3672-9
PMID: 2824806
-
p21-containing cyclin kinases exist in both active and inactive states.
Genes Dev. 1994 Aug 1;8(15):1750-8
PMID: 7958854
-
Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control.
Cell. 1995 Aug 25;82(4):675-84
PMID: 7664346
-
Epstein-barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma.
Mol Cell Biol. 1999 Mar;19(3):1651-60
PMID: 10022853
-
Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
Proc Natl Acad Sci U S A. 1989 Dec;86(23):9558-62
PMID: 2556717
-
Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.
Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8292-7
PMID: 9653180
-
Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1.
J Virol. 2010 Mar;84(6):2893-901
PMID: 20042495
-
Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells.
Proc Natl Acad Sci U S A. 2006 Dec 19;103(51):19500-5
PMID: 17159137
-
The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors.
EMBO J. 1996 Jun 3;15(11):2748-59
PMID: 8654372
-
The central acidic domain of MDM2 is critical in inhibition of retinoblastoma-mediated suppression of E2F and cell growth.
J Biol Chem. 2004 Dec 17;279(51):53317-22
PMID: 15485814
-
Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.
Semin Cancer Biol. 2009 Dec;19(6):377-88
PMID: 19619657
-
Lamin proteolysis facilitates nuclear events during apoptosis.
J Cell Biol. 1996 Dec;135(6 Pt 1):1441-55
PMID: 8978814
-
A DNA vector-based RNAi technology to suppress gene expression in mammalian cells.
Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5515-20
PMID: 11960009
-
EBNA-2 and EBNA-3C extensively and mutually exclusively associate with RBPJkappa in Epstein-Barr virus-transformed B lymphocytes.
J Virol. 1996 Jun;70(6):4179-83
PMID: 8648764
-
Epstein-barr virus-induced resistance to drugs that activate the mitotic spindle assembly checkpoint in Burkitt's lymphoma cells.
J Virol. 2007 Jan;81(1):248-60
PMID: 17035311
-
p21(Waf1/Cip1/Sdi1) mediates retinoblastoma protein degradation.
Oncogene. 2007 Oct 18;26(48):6954-8
PMID: 17486059
-
Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein.
J Virol. 1996 Jan;70(1):623-7
PMID: 8523583
-
A fifth Epstein-Barr virus nuclear protein (EBNA3C) is expressed in latently infected growth-transformed lymphocytes.
J Virol. 1988 Apr;62(4):1330-8
PMID: 2831394
-
Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter.
J Virol. 2006 Nov;80(22):11200-8
PMID: 16956945
-
Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP.
PLoS Pathog. 2010 Jun 10;6(6):e1000951
PMID: 20548956
-
Epstein-Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth.
J Virol. 2003 Oct;77(19):10437-47
PMID: 12970429
-
Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes.
Proc Natl Acad Sci U S A. 1990 Mar;87(5):1725-9
PMID: 2155423
-
Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells.
Proc Natl Acad Sci U S A. 1982 Dec;79(24):7837-41
PMID: 6818551
-
DNA sequence and expression of the B95-8 Epstein-Barr virus genome.
Nature. 1984 Jul 19-25;310(5974):207-11
PMID: 6087149
-
Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit.
Nature. 1993 Dec 16;366(6456):707-10
PMID: 8259216
-
WAF1, a potential mediator of p53 tumor suppression.
Cell. 1993 Nov 19;75(4):817-25
PMID: 8242752
-
Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53.
EMBO J. 1995 Apr 3;14(7):1382-91
PMID: 7729416
-
Cdc25 cell-cycle phosphatase as a target of c-myc.
Nature. 1996 Aug 8;382(6591):511-7
PMID: 8700224
-
New functional activities for the p21 family of CDK inhibitors.
Genes Dev. 1997 Apr 1;11(7):847-62
PMID: 9106657
-
PUMA, a novel proapoptotic gene, is induced by p53.
Mol Cell. 2001 Mar;7(3):683-94
PMID: 11463392
-
Epstein-Barr virus LMP1 blocks p16INK4a-RB pathway by promoting nuclear export of E2F4/5.
J Cell Biol. 2003 Jul 21;162(2):173-83
PMID: 12860972
-
Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro.
J Virol. 1992 May;66(5):2893-903
PMID: 1313908
-
MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein.
Mol Cell. 2005 Dec 9;20(5):699-708
PMID: 16337594
-
Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis.
Oncogene. 1992 Sep;7(9):1775-82
PMID: 1354347
-
Lymphomas differ in their dependence on Epstein-Barr virus.
Blood. 2011 Feb 10;117(6):1977-85
PMID: 21088132
-
Complex transcription of the Epstein-Barr virus BamHI fragment H rightward open reading frame 1 (BHRF1) in latently and lytically infected B lymphocytes.
Proc Natl Acad Sci U S A. 1988 Jun;85(11):3678-82
PMID: 2836854
-
Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis.
EMBO J. 1996 Dec 16;15(24):6969-78
PMID: 9003773
-
African Burkitt's lymphoma. History, biology, clinical features, and treatment.
Am J Pediatr Hematol Oncol. 1991 Summer;13(2):222-46
PMID: 2069232
-
Two nonconsensus sites in the Epstein-Barr virus oncoprotein EBNA3A cooperate to bind the co-repressor carboxyl-terminal-binding protein (CtBP).
J Biol Chem. 2002 Dec 6;277(49):47197-204
PMID: 12372828
-
mdm2 expression is induced by wild type p53 activity.
EMBO J. 1993 Feb;12(2):461-8
PMID: 8440237
-
Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.
Oncogene. 1991 Oct;6(10):1915-22
PMID: 1923514
-
The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2.
J Virol. 1999 May;73(5):4481-4
PMID: 10196351
-
Modulation of p53 expression using antisense oligonucleotides complementary to the 5'-terminal region of p53 mRNA in vitro and in the living cells.
PLoS One. 2013 Nov 11;8(11):e78863
PMID: 24244378
-
The pathogenesis of Burkitt's lymphoma.
Adv Cancer Res. 1990;55:133-270
PMID: 2166998
-
Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.
Nat Med. 2002 Oct;8(10):1098-104
PMID: 12219084
-
Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.
J Virol. 2009 May;83(9):4652-69
PMID: 19244339
-
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Cell. 1993 Nov 19;75(4):805-16
PMID: 8242751
-
Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines.
PLoS Pathog. 2013 Feb;9(2):e1003187
PMID: 23436997
-
The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts.
EMBO J. 1999 Mar 15;18(6):1571-83
PMID: 10075928
-
A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus.
J Virol. 1987 Nov;61(11):3424-30
PMID: 2822952
-
An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link.
PLoS Pathog. 2009 Mar;5(3):e1000341
PMID: 19283066
-
BamHI E region of the Epstein-Barr virus genome encodes three transformation-associated nuclear proteins.
Proc Natl Acad Sci U S A. 1988 Feb;85(4):995-9
PMID: 2829223
-
A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jkappa.
J Virol. 1996 Jul;70(7):4228-36
PMID: 8676443
-
p21 is a universal inhibitor of cyclin kinases.
Nature. 1993 Dec 16;366(6456):701-4
PMID: 8259214
-
Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.
J Virol. 2000 Jun;74(11):5151-60
PMID: 10799590
-
Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.
EMBO J. 1987 Sep;6(9):2743-51
PMID: 2824192
-
Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes.
PLoS Pathog. 2009 Jul;5(7):e1000506
PMID: 19578441